DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...

The traditional standard of care for glucose monitoring was a fingerstick meter, which was painful as some patients had to test their blood by pricking their fingers up to 12 times a day.

After getting the green light from the FDA back in March, Dexcom today launched its first over-the-counter wearable continuous glucose biosensor, Stelo, in the U.S. market. The device is now ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology ...

“Dexcom has been at the forefront of glucose ... If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare ...

Today, Benzinga 's options scanner spotted 8 uncommon options trades for DexCom. This isn't normal. The overall sentiment of ...

New over-the-counter sensors, an Abbott-Medtronic partnership and Roche’s first CGM are among diabetes technology’s top stories so far in 2024. Check out MedTech Dive’s roundup of the latest news.

13 Diabetes technology like Dexcom CGM could not only improve their ... must continuously have their smartphone within 20 ...

This field is practically a duopoly DexCom shares with Abbott Laboratories. CGMs are better mousetraps than manually operated blood glucose meters that can only tell a person's sugar level at a ...

Brown, Dexcom Head of Market Access discusses diabetes management. The views expressed here are not necessarily those of The Scotsman and it is recommended to always seek NHS advice before commencing ...